132 related articles for article (PubMed ID: 21271253)
1. [Acute loss of vision during therapy of chronic hepatitis C].
Salgado JP; Khoramnia R; Maier MM; Lohmann CP; Winkler von Mohrenfels C
Ophthalmologe; 2011 Jun; 108(6):561-4. PubMed ID: 21271253
[TBL] [Abstract][Full Text] [Related]
2. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
Such Díaz A; Barrueco N; Esteban Alba C; Escobar Rodríguez I
Farm Hosp; 2011; 35(2):93-4. PubMed ID: 20615736
[No Abstract] [Full Text] [Related]
3. Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C.
Goncalves LL; Farias AQ; Gonçalves PL; D'Amico EA; Carrilho FJ
World J Gastroenterol; 2006 Jul; 12(28):4602-3. PubMed ID: 16874884
[TBL] [Abstract][Full Text] [Related]
4. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection. A rare complication.
Ortega-Ibarra FS; Remes-Troche JM
Rev Esp Enferm Dig; 2013; 105(5):291-2. PubMed ID: 23971660
[No Abstract] [Full Text] [Related]
5. Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C.
Watanabe M; Ogasawara S; Takahashi A; Takada J; Tanaka Y; Okuwaki Y; Minamino T; Hidaka H; Nakazawa T; Shibuya A; Koizumi W
Cutan Ocul Toxicol; 2012 Sep; 31(3):253-7. PubMed ID: 22172047
[TBL] [Abstract][Full Text] [Related]
6. Pegylated interferon-associated severe retinopathy in a patient with chronic hepatitis.
Kang HY; Shin MC
Korean J Ophthalmol; 2012 Apr; 26(2):147-50. PubMed ID: 22511844
[TBL] [Abstract][Full Text] [Related]
7. Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C.
Zandieh I; Adenwalla M; Cheong-Lee C; Ma PE; Yoshida EM
World J Gastroenterol; 2006 Aug; 12(30):4908-10. PubMed ID: 16937480
[TBL] [Abstract][Full Text] [Related]
8. Cystoid macular edema and visual loss as sequelae to interferon alpha treatment of systemic hepatitis C.
Sheth HG; Michaelides M; Siriwardena D
Indian J Ophthalmol; 2010; 58(2):147-8. PubMed ID: 20195039
[TBL] [Abstract][Full Text] [Related]
9. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
Hu CC; Chien RN
Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
[No Abstract] [Full Text] [Related]
10. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
[TBL] [Abstract][Full Text] [Related]
11. Ischemic colitis during interferon-ribavirin therapy for chronic hepatitis C: a case report.
Baik SJ; Kim TH; Yoo K; Moon IH; Cho MS
World J Gastroenterol; 2012 Aug; 18(31):4233-6. PubMed ID: 22919260
[TBL] [Abstract][Full Text] [Related]
12. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
Demirturk N; Aykin N; Demirdal T; Cevik F
Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
[No Abstract] [Full Text] [Related]
13. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
Ann Intern Med; 2013 Dec; 159(11):I-14. PubMed ID: 24297207
[No Abstract] [Full Text] [Related]
14. Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).
Couzigou P; Pérusat S; Bourlière M; Trimoulet P; Poynard T; Leroy V; Marcellin P; Foucher J; Bronowicki JP; Chêne G;
J Gastroenterol Hepatol; 2013 Feb; 28(2):329-34. PubMed ID: 23190183
[TBL] [Abstract][Full Text] [Related]
15. Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C.
Choi JW; Lee JS; Paik WH; Song TJ; Kim JW; Bae WK; Kim KA; Kim JG
Clin Mol Hepatol; 2016 Mar; 22(1):168-71. PubMed ID: 27044768
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
17. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
Kim ET; Kim LH; Lee JI; Chin HS
Jpn J Ophthalmol; 2009 Nov; 53(6):598-602. PubMed ID: 20020238
[TBL] [Abstract][Full Text] [Related]
18. Reversible sudden sensorineural hearing loss during chronic hepatitis C treatment with pegylated interferon/ribavirin.
Papastergiou V; Skorda L; Lisgos P; Karatapanis S
Acta Gastroenterol Belg; 2011 Dec; 74(4):582-4. PubMed ID: 22319972
[No Abstract] [Full Text] [Related]
19. De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).
Fabrizi F; Aghemo A; Moroni G; Passerini P; D'Ambrosio R; Martin P; Messa P
Dig Dis Sci; 2014 Mar; 59(3):691-5. PubMed ID: 24318802
[No Abstract] [Full Text] [Related]
20. Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b.
Scotto G; Fazio V; Fornabaio C; Tartaglia A; Di Tullio R; Saracino A; Angarano G
Drugs; 2008; 68(6):791-801. PubMed ID: 18416586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
